Lyra Therapeutics Earnings Estimates, EPS & Revenue | OTC:LYRA

Comments

Lyra Therapeutics Inc Earnings Estimates

LYRAOTCPK

Trade with Public

$0.4950

At close: Mar 26, 5:00 PM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest

Lyra Therapeutics Earnings Estimates, EPS & Revenue | OTC:LYRA

Lyra Therapeutics (LYRA) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $-1.36 and quarterly revenue of N/A.

In the most recent quarter (Q4), Lyra Therapeutics reported EPS of $-3.77, beating estimates of $-4.78 by 0.21%. Revenue came in at $7.00K, missing the estimate of $187.00K by 0.96%.

Lyra Therapeutics has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Lyra Therapeutics has averaged an EPS surprise of 0.16% and a revenue surprise of 0.50%.

Earnings Date

May 5

EPS Estimate

$-1.360

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

$398.00K

Lyra Therapeutics Earnings History

Analyze the earnings history of Lyra Therapeutics using advanced sorting and filters.

Loading calendar...

Lyra Therapeutics (LYRA) Earnings Per Share

The chart below shows Lyra Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q4	2026-03-31	$-3.77	$-4.78	21.1 %
Q3	2025-11-12	$-3.38	$-4.83	30.0 %
Q2	2025-08-12	$-5.51	$-5.18	-6.37 %
Q1	2025-05-06	$-6.50	$-6.83	4.83 %

Lyra Therapeutics (LYRA) Revenue

The chart below shows Lyra Therapeutics's reported revenue compared to analyst estimates over recent quarters.

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q4	2026-03-31	$7.00K	$187.00K	-96.3 %
Q3	2025-11-12	$25.00K	$136.55K	-81.7 %
Q2	2025-08-12	$183.00K	$168.75K	8.44 %
Q1	2025-05-06	$183.00K	$160.00K	14.4 %

FAQ

When is Lyra Therapeutics (OTCPK:LYRA) reporting earnings?

Lyra Therapeutics (LYRA) is scheduled to report earnings on May 5, 2026. The last reported earnings were for reported on March 31, 2026 for Q4.

What were the latest earnings per share (EPS) for Lyra Therapeutics (OTCPK:LYRA)?

The Actual EPS was $-3.77, which beat the estimate of $-4.78.

What were Lyra Therapeutics’s (OTCPK:LYRA) revenues?

The Actual Revenue was $7.00K, which missed the estimate of $187.00K.

Lyra Therapeutics Earnings Estimates, EPS & Revenue | OTC:LYRA

Lyra Therapeutics (LYRA) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $-1.36 and quarterly revenue of N/A.

In the most recent quarter (Q4), Lyra Therapeutics reported EPS of $-3.77, beating estimates of $-4.78 by 0.21%. Revenue came in at $7.00K, missing the estimate of $187.00K by 0.96%.

Lyra Therapeutics has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Lyra Therapeutics has averaged an EPS surprise of 0.16% and a revenue surprise of 0.50%.

Earnings Date

May 5

EPS Estimate

$-1.360

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

$398.00K